Future Pharma 2024
June 25 - 27, 2024
The Westin Copley Place, Boston, MA
Day 2 - June 27th
Refining Strategies for Success
6:30 am - 7:30 am
Future Pharma Boston Group Run
Feeling motivated after a full day of networking and learning? Join some of your peers at the hotel lobby for a fun group run around Boston's Back Bay neighborhood. Put in some miles before tackling another day at Future Pharma
8:00 am - 9:00 am
Networking Breakfast | Women in Pharma Networking Breakfast
9:00 am - 9:15 am
Welcome Remarks
9:15 am - 9:30 am
Chairperson's Opening Remarks
Bill Berry -
General Manager of Lifesciences and Healthcare,
Constellation
9:30 am - 9:50 am
Opening Keynote Case Study | Developing Sound Strategies: Understanding Your Organization’s Dynamics to Create Value as a Leader
Jonathan Miller -
Head of Commercial Excellence,
Ipsen
9:50 am - 10:10 am
Partner Keynote Presentation | How the Relationship with Advertising Agencies is Evolving in the Face of Tighter Budgets and Increased Technological Innovation
Advertising Partners are key to getting creative messages out to target audiences. However, there is no one size fits all approach to developing these important relationships. As market forces change and technology makes it easier for teams to execute on different initiatives, many are beginning to look at agency relationships and wondering what the future will hold. This partner presentation will dive into the world of agency partnerships and will showcase the benefits of traversing new economic and technological landscapes with a trusted partner.
Speaker TBD, Syneos Health
10:10 am - 10:30 am
Keynote Presentation | Patient Power: Revolutionizing Marketing Through Patient-Centric Influence on Healthcare Providers
Stephanie Loiseau -
Head of Marketing,
SK Life Science
10:30 am - 11:00 am
Panel Discussion with Live Polling | Women in Pharma Leadership Forum
Gwen Hyland -
Head of Commercial Excellence, Rare Disease,
Alexion
Leisha Martin -
Executive Director, Global Head of Quality,
Dermavant
The list of women in leadership positions continues to grow in the Pharma Business, but it hasn’t always been an easy road to the top. Our esteemed panel will lead an open and honest conversation around challenges faced as a woman in life sciences and expectations for the future of leadership development. Additionally, the panel will address:
- The journeys of women in yesterday and today’s industry
- The future of work and the role female leaders play navigating change.
- What male allies can do to help foster growth and development.
- Meaningful Q&A discussion
11:00 am - 11:40 am
Morning Boost Refreshment Break
Enhancing Patient Centricity
11:40 am - 12:10 pm Panel Discussion with Live Polling | The Importance of Equitable Access for Sustained Brand Success Louis Savant - Director, Patient Access Transformation Strategies, Teva Pharmaceuticals Jenny Rudolph - AD, Payer Access Marketing, Boehringer Ingelheim Jill Pearcy - Director, Reputation, Association of the British Pharmaceutical Industry (ABPI)Ensuring equitable access to medication is a key moral and commercial imperative for leaders, and learning how to communicate with a wider patient base is at the top of proficiencies that teams are investing in. Join us for a panel that will tie together the worlds of market access and patient marketing to showcase just how and why it is so important to ensure that access to medication, and the way we share and educate patients on it, is meaningful and equitable.
Enhancing Patient Centricity
12:10 pm - 12:30 pm Case Study | Empowering Patients: Unveiling the Empirical Value of Fixed-Dose versus Mono Combinations Therapies Christian Schaffer - Professor of Business Administration and Quantitative Methods, Baden-Württemberg University - MannheimWe examine the comparative importance of fixed-dose combinations (FDCs) versus combinations of MONOs (monotherapies) from the patient's perspective. In addition, we evaluate the relative importance of Mechanisms of Action (MOAs) compared to FDCs. In terms of patient satisfaction, the choice between FDC and MONO is significantly more important than the prescribed MOAs. We also examine the impact of MOAs, FDCs, and MONOs on patients' ability to manage their treatment regimen and their emotional response to therapy, satisfaction, and adherence.
The Patient Matrix (PM) model we present serves as an extended framework to elucidate the empirical significance of FDC prescribing, where applicable. These findings provide valuable insights for pharmaceutical companies to further empower patients and adopt a more patient-centric approach.
Christian Schaffer
Professor of Business Administration and Quantitative MethodsBaden-Württemberg University - Mannheim
Enhancing Patient Centricity
12:30 pm - 1:00 pm Panel Discussion | Why Patient Services and Patient Advocacy Teams are Key to Ensuring Success in Patient CentricityOne of Pharma’s main goals as an industry is promoting patient centricity in everything it does. This means aligning their efforts to match what is ultimately best for the patient and their families. Patient Services and Patient Advocacy Teams contribute to the success of patient-centricity in pharmaceutical marketing by fostering a deep understanding of patient needs, improving patient experiences, building trust, and ensuring that products and services align with the realities of patients' lives. Join us as we look at the different insights that patient services and patient advocacy teams provide marketing and commercial leaders which enhance their patient centric strategies and allows for a greater sense of the patient needs.
Internal Workforce Optimization
11:40 am - 12:10 pm Panel Discussion | Fostering Innovation in Times of Change and Hiring for Future Success Christopher Nugent - Director, Commercial Innovation, Sumitovant Biopharma Daniel Fernandez - Director, Commercial Strategy, GenentechThere is a tremendous amount of change happening at different levels and speed throughout the pharma industry. As organizations consolidate, merge, acquire and disband, keeping teams creative and willing to push the boundaries of innovation can be difficult for many leaders to do. As technology makes innovation easier, having the right folks in place that can not only bring different skills to the table, but also bring different perspectives will be the ultimate game changer. This panel will look at ways that leaders can create and nourish an environment of innovation while developing teams that will leverage new skills and tools that will enable future success.
Daniel Fernandez
Director, Commercial StrategyGenentech
Internal Workforce Optimization
12:10 pm - 12:30 pm Case Study | Why Diversity Matters in Our FieldDiversity in pharmaceutical marketing and commercialization is one of the most important ingredients in the recipe for success. If you want to reach patients from different populations and ensure that your messaging is crafted in a way that resonates, you need a diverse set of employees and leaders to help develop the right type of content and delivery methods. So why does diversity matter? What are the benefits of building an inclusive and diverse workforce? Who stands to ultimately gain from incorporating DE&I into our working environments? Join us as we look at the multitude of benefits that diversity brings to not only our work lives, but our overall wellbeing.
Internal Workforce Optimization
12:30 pm - 1:00 pm Panel Discussion | Life Happens – Bouncing Back and Building Resilience as Working Professionals Timmy Ford - Field Vice President, Vaccines, GSK Jennifer Muszik - Commercial Learning, Leadership Development, Executive Leadership, AlkermesDeath of a parent; relocating your family across the country; coaching your son’s little league team – our panelists have lives outside of their day jobs, and they’ve each expressed that striking that balance between their work lives and their personal lives continues to be one of their biggest challenges. During this panel, we will discuss tips and tricks for juggling all of lives surprises with their work in the demanding industry of pharma. Our panelists will touch on:
• What happens when life interrupts and how to maintain a proper work/life balance
• Keeping up your status as a high performer and effective worker during times of disruption
• Key learnings from personal experience
1:00 pm - 2:00 pm
Lunch
2:10 pm - 2:30 pm
Fireside Chat | Lessons Learned in Breaking Down Internal Silos: Argenx’s Journey in Helping Sales & Marketing Teams Work Better Together
Joy Chen -
Associate Director, Digital Marketing,
Argenx
Stacey Fagiolo -
Territory Business Manager,
Argenx
2:30 pm - 2:50 pm
Keynote Presentation | Biosimilars in An Evolving Policy Landscape
Dinakaran Balasubramanian -
Head of Commercial Strategy & Insights for Biologics - North America,
Dr. Reddy's Laboratories
Dinakaran Balasubramanian
Head of Commercial Strategy & Insights for Biologics - North AmericaDr. Reddy's Laboratories
2:50 pm - 3:10 pm
Keynote Presentation | Review of the VC Environment for Healthcare
Kent Rogers -
former Chief Customer Officer,
EQRx
3:10 pm - 3:40 pm
Panel Discussion | Looking Outside of Pharma to Improve CX
Nicholas Maglietta -
Manager, Search Marketing,
Zoetis
John Curcio -
former Head of US Digital eServices Marketing,
Roche
Brian Peters -
former VP, Marketing & Sales,
Medexus Pharma
Pharma’s digital revolution has allowed for brand new technologies and insights to be introduced into the workflow. While the capacity to garner information on our customers has gotten better, there is still the need to build creative capabilities to put those insights to good use. Our conversation will explore ways pharma marketers can look outside of the industry to draw inspiration on how to approach their marketing campaigns.
